About this trial
The e-Intervention Enhancing Mental Health in Adolescents (IMPROVA) study will co-design, test, evaluate, and facilitate the upscaling of a modular eHealth intervention platform that aims to improve mental health and wellbeing, early detect mental health problems and prevent common mental problems in adolescents. IMPROVA will be implemented in school settings and will include components for adolescents, parents, teachers, and other school staff in complementary and synergistic modules based on materials designed and tested in \>20 projects carried out by the consortium members. After alpha, beta and pilot testing of the platform, the IMPROVA program will be implemented via a randomised controlled trial in secondary education schools in France, Germany, Romania and Spain, including approximately 6,000 adolescents. A 360º evaluation of IMPROVA will include Effectiveness, Implementation, Economic, and Social Return on Investment analysis. The primary outcome to assess the effectiveness of the IMPROVA program is the overall mental health of adolescents. A series of secondary outcomes will also evaluate the potential impact of the platform on other health-related outcomes (e.g., wellbeing, social isolation, anxiety, life satisfaction). Using implementation science methodology, IMPROVA will co-design transferable evidence-based guidance for scaling up the platform with users and policymakers. IMPROVA aims to provide an evidence-based, innovative, large-scale, comprehensive intervention, and a scale-up plan to promote mental health and prevent mental disorders in adolescents; empower adolescents and families to make better decisions regarding their mental health; and provide schools and the community with tools to achieve a society with better mental health and lower stigma.
Eligibility criteria
Qualifiers
Adolescents enrolled in the selected secondary schools will be eligible.
Parents of adolescents enrolled in the selected schools will be eligible
Teachers and school staff: All teachers and school staff working in the selected schools will be eligible.
Participants can be of any gender.
Disqualifiers
None
Trial design
Treatments tested in this trial
- IMPROVA Platform
Treatment groups
Locations
Sponsors and collaborators
Fundació Sant Joan de Déu
Lead sponsor
Babes-Bolyai University
Collaborator
Linkoeping University
Collaborator
Betthera s.r.o.
Collaborator
Wuerzburg University Hospital
Collaborator
University of Ulm
Collaborator
Utrecht University
Collaborator
Ajuntament de Sant Boi de Llobregat
Collaborator
VU University of Amsterdam
Collaborator
Institut National de la Santé Et de la Recherche Médicale, France
Collaborator
Stichting Trimbos-Instituut
Collaborator
University of Deusto
Collaborator
Cliclab Transformative Agent SL
Collaborator